Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/49321
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMaury, Eleonore-
dc.contributor.authorvan der Linden, Lorenz-
dc.contributor.authorBOGAERTS, Kris-
dc.contributor.authorBELMANS, Ann-
dc.contributor.authorJansen, Mieke-
dc.date.accessioned2026-06-16T12:11:03Z-
dc.date.available2026-06-16T12:11:03Z-
dc.date.issued2026-
dc.date.submitted2026-06-16T12:05:22Z-
dc.identifier.citationDrugs & aging, 43 (1) , p. 89 -98-
dc.identifier.urihttp://hdl.handle.net/1942/49321-
dc.description.abstractHeart failure with reduced ejection fraction is increasingly prevalent in older adults, yet data on guideline-directed therapies in the oldest age groups remain limited.-
dc.description.sponsorshipFunding This work was funded by Novartis Pharma Belgium Acknowledgements Healthdata.be, Sciensano, Brussels, Belgium facilitated data exchange for this study, enabling the analysis of this Belgian registry. We sincerely thank the FPS Public Health, Safety of the Food Chain and Environment for their invaluable support in enabling the publication of our research. We thank the members of the cardio-renal-metabolic medical department, market access, regulatory, and pharmacovigilance teams at Novartis Pharma Belgium for their helpful discussions, with special acknowledgment to Rozan Yagan and Joachim Vandepitte (Pharmacovigilance, Patient Safety) and Sven De Mey (Medical Affairs) for their constructive comments, which have improved this work. The authors honor the late Stefaan Vancayzeele, MD, PhD, who conceptualized the initial design of this study and contributed significantly to its foundation. His vision and dedication have been instrumental to the conduct of this research.-
dc.language.isoen-
dc.publisherADIS INT LTD-
dc.rightsThe Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.-
dc.subject.otherHumans-
dc.subject.otherAged-
dc.subject.otherAged, 80 and over-
dc.subject.otherDrug Combinations-
dc.subject.otherMale-
dc.subject.otherFemale-
dc.subject.otherRetrospective Studies-
dc.subject.otherBelgium-
dc.subject.otherAge Factors-
dc.subject.otherTreatment Outcome-
dc.subject.otherHeart Failure-
dc.subject.otherBiphenyl Compounds-
dc.subject.otherValsartan-
dc.subject.otherAminobutyrates-
dc.subject.otherStroke Volume-
dc.subject.otherHospitalization-
dc.subject.otherAngiotensin Receptor Antagonists-
dc.titleEffectiveness of Sacubitril/Valsartan in Reducing Hospitalizations in Older Belgian Adults with Heart Failure and Reduced Ejection Fraction: An Age-Stratified Study-
dc.typeJournal Contribution-
dc.identifier.epage98-
dc.identifier.issue1-
dc.identifier.spage89-
dc.identifier.volume43-
local.format.pages10-
local.bibliographicCitation.jcatA1-
local.publisher.place5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1007/s40266-025-01265-7-
dc.identifier.pmid41266857-
dc.identifier.isi001619683400001-
local.provider.typeWeb of Science-
local.uhasselt.internationalno-
item.fulltextWith Fulltext-
item.fullcitationMaury, Eleonore; van der Linden, Lorenz; BOGAERTS, Kris; BELMANS, Ann & Jansen, Mieke (2026) Effectiveness of Sacubitril/Valsartan in Reducing Hospitalizations in Older Belgian Adults with Heart Failure and Reduced Ejection Fraction: An Age-Stratified Study. In: Drugs & aging, 43 (1) , p. 89 -98.-
item.contributorMaury, Eleonore-
item.contributorvan der Linden, Lorenz-
item.contributorBOGAERTS, Kris-
item.contributorBELMANS, Ann-
item.contributorJansen, Mieke-
item.accessRightsOpen Access-
crisitem.journal.issn1170-229X-
crisitem.journal.eissn1179-1969-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
s40266-025-01265-7.pdfPublished version478.71 kBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.